Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01929902 · ClinicalTrials.gov registry record
Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 20
- Enrollment target
NCT01929902: Completed study, sponsored by Wake Forest University Health Sciences.
NCT01929902 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01929902 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy and accuracy of the Aquamantys device.
Primary Outcome
Efficacy of device will be measured based on intra-operative and post-operative complication variables: estimated blood loss, blood transfusion, complications intra-operative and post-operative.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-03 |
What the finished NCT01929902 record still lists
NCT01929902 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01929902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01929902 about?
NCT01929902 is a clinical study titled "Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery". The purpose of this study is to test the efficacy and accuracy of the Aquamantys device.
What is the current status of trial NCT01929902?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2013-07. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT01929902?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia